Energy & environment · 10/07/2008Updated: 10/17/2026 · 1 min read
GlaxoSmithKline Announces Availability of Environmental Assessment for Unrestricted Release of Building 11 at Hamilton Facility
Summary
The US Environmental Protection Agency has made available an environmental assessment and finding of no significant impact for a license amendment to allow unrestricted release of building 11 at the GlaxoSmithKline Biologicals-Hamilton facility in Hamilton, Montana, under license number 25-19852-01.